Abbott Laboratories (Pakistan) Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was PKR 10,649.31 million compared to PKR 8,438.24 million a year ago. Revenue was PKR 10,649.31 million compared to PKR 8,438.24 million a year ago. Net income was PKR 1,209.91 million compared to PKR 985.44 million a year ago. Basic earnings per share from continuing operations was PKR 12.36 compared to PKR 10.07 a year ago. For the nine months, sales was PKR 31,447.29 million compared to PKR 24,971.91 million a year ago. Revenue was PKR 31,447.29 million compared to PKR 24,971.91 million a year ago. Net income was PKR 4,491.9 million compared to PKR 3,105.51 million a year ago. Basic earnings per share from continuing operations was PKR 45.88 compared to PKR 31.72 a year ago.